Skip to main content
SpringerLink
Log in

Myocardial Protection — From Concepts to Clinical Practice

  • Chapter
Book cover Myocardial Ischemia

Part of the book series: Basic Science for the Cardiologist ((BASC,volume 21))

  • 699 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. R. P. Taylor, J. T. Ciccolo, J. W. Starnes, Effect of exercise training on the ability of the rat heart to tolerate hydrogen peroxide, Cardiovasc Res 58, 575–581 (2003).

    Article  CAS  PubMed  Google Scholar 

  2. J. L. Martin, R. Mestril, R. Hilal-Dandan, L. L. Brunton, W. H. Dillmann, Small heat shock proteins and protection against ischemic injury in cardiac myocytes, Circulation 96, 4343–4348 (1997).

    CAS  PubMed  Google Scholar 

  3. C. E. Muny, RB. Jennings, K. A. Reimer, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation 75, 1124–1136 (1986).

    Google Scholar 

  4. F. Ottani, M. Galvani, D. Ferrini, F. Sorbello, P. Limonetti, D. Pantoli, F. Rusticali, Prodromal angina limits infarct size. A role for ischemic preconditioning, Circulation 91, 291–297 (1995).

    CAS  PubMed  Google Scholar 

  5. Y. Nakagawa, H. Ito, M. Kitakaze, H. Kusuoka, M. Hori, T. Kuzuya, Y. Higashino, K. Fujii, T. Minamino, Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of “preconditioning”, J Am Coll Cardiol 25, 1076–1083 (1995).

    Article  CAS  PubMed  Google Scholar 

  6. N. A. Ruocco, B. A. Bergelson, A. K. Jacobs, M. M. Frederick, D. P. Faxon, T. J. Ryan, Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction phase II study (TIMI 11), J Am Coll Cardiol 20, 1445–1551 (1992).

    PubMed  Google Scholar 

  7. D. W.M. Muller, E. J. Topol, R. M. Califf, K. N. Sigmon, L. Gorman, B. S. George, D. L. Kereiakis, K.L. Lee, S. G. Ellis, TAM1 study Group. Relationship between antecedent angina pectoris and short term prognosis after thrombolytic therapy for acute myocardial infarction, Am Heart J 119. 224–31 (1990).

    CAS  PubMed  Google Scholar 

  8. R. A. Kloner, T. Shook, K. Przyklenk, V. G. Davis, L. Junio, R. V. Matthews, S. Burstein, C. M. Gibson, W. K. Poole, C. P. Cannon, C. H. McCabe, E. Brawnwald, for the TIM1 4 investigators, Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 91, 3745 (1995).

    Google Scholar 

  9. M. Ishihara, H. Sato, H. Tateishi, T. Kawagoe, Y. Shimatani, S. Kurisu, K. Sakai, K. Ueda, Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis, J Am Coll Cardiol 31, 1701 (1998).

    Article  Google Scholar 

  10. P. Taggart, D. M. Yellon, Preconditioning and arrhythmias, Circulation 106, 2999–3001 (2002).

    Article  PubMed  Google Scholar 

  11. G. I. Barbash, H. D. White, M. Modan, F. Van de Werf, Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial, J Am Coll Cardiol 20, 6–41 (1992).

    Google Scholar 

  12. F. Ottani, M. Galvani, D. Ferrini, Angina and Cardiac adaptation. In: Delayed preconditioning and adaptive cardioprotection. G. F. Baxter, D. M. Yellon, eds Kluwer Academic Publishers, Dordrecht, pp. 209–224 (1998).

    Google Scholar 

  13. A. D. Cokkinos, S. Tzeis, P. Moraitis, C. Pantos, H. Carageorgiou, D. Panousopoulos, D. D. Varonos, D. V. Cokkinos, Loss of cardioprotection induced by ischemic preconditioning after an initial ischemic period in isolated rat hearts, Exp Clin Cardiol 8, 5–9 (2003).

    PubMed  Google Scholar 

  14. P. Abete, N. Ferrara, A. Cioppa, P. Ferrara, S. Bianco, C. Calabrese, F. Cacciatore, G. Longobardi, F. Rengo, Preconditioning does not prevent postischemic dysfunction in ageing heart, J Am Coll Cardiol 27, 1777–86 (1996).

    Article  CAS  PubMed  Google Scholar 

  15. M. Tani, Y. Honma, H. Hasegawa, K. Tamaki, Direct activation of mitochondrial KATP channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts, Cardiovascular Research 49, 56–68 (2001).

    Article  CAS  PubMed  Google Scholar 

  16. P. Abete, C. Calabrese, N. Ferrara, A. Cioppa, P. Pisanelli, F. Cacciatore, G. Longobardi, C. Napoli, F. Rengo, Exercise training restores ischemic preconditioning in the ageing heart, J Am Coll Cardiol 36, 643–50 (2000).

    Article  CAS  PubMed  Google Scholar 

  17. E. J. Baker, LE. Boerboom, G. N. Olinger, J. E. Baker, Tolerance of the developing heart to ischemia: impact of hypoxemia from birth, Am J Physiol 268, H1165–73 (1995).

    CAS  PubMed  Google Scholar 

  18. K. Iwaki, S. Chi, W. H. Dillmann, R. Mestril, Induction of Hsp70 in cultured rat neonatal cardiomyocytes by hypoxia and metabolic stress, Circulation 87, 2023–2032 (1993).

    CAS  PubMed  Google Scholar 

  19. J. E. Baker, P. Holman, G. J. Gross, Preconditioning in immature rabbit hearts: Role of KATP channels, Circulation 99, 1249–1254 (1999).

    CAS  PubMed  Google Scholar 

  20. W. I. Awad, M. J. Shanock, D. J. Chambers, Ischemic preconditioning in immature myocardium, Circulation 98, II-206–II-213 (1998).

    CAS  Google Scholar 

  21. G. Hadour, R. Ferrera, L. Sebbag, R. Forrat, J. Delaye, M. de Lorgeril, Improved myocardial tolerance to ischemia in the diabetic rabbit, J Mol Cell Cardiol 30, 1869–75 (1998).

    Article  CAS  PubMed  Google Scholar 

  22. A. Tosaki, D. T. Engelman, R. M. Engelman, D. K. Das, The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts, Cardiovasc Res 31(4), 526–36 (1996).

    Article  CAS  PubMed  Google Scholar 

  23. T. Ravingerova, J. Neckar, F. Kolar, R. Stetka, K. Volkovova, A. Ziegelhoffer, J. Styk, Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischemia? Basic Res Cardiol 96, 160–168 (2001).

    Article  CAS  PubMed  Google Scholar 

  24. P. Ferdinandy, Z. Szilvassy, G. F. Baxter, Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci 19, 223–9 (1998).

    Article  CAS  PubMed  Google Scholar 

  25. L. Szekeres, Z. Szilvassy, P. Ferdinandy, I. Nagy, S. Karscu, S. Csati, Delayed cardiac protection against harmful consequences of stress can be induced in experimental atherosclerosis in rabbits, J Mol Cell Cardiol 129, 1977–83 (1997).

    Article  Google Scholar 

  26. D. Kremastinos, E. Bofilis, G. Karavolias, A. Papalois, L. Kaklamanis, E. Iliodromitis, Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits, Atherosclerosis 150, 81–85 (2000).

    Article  CAS  PubMed  Google Scholar 

  27. C. Pantos, V. Malliopoulou, D. Varonos, D. V. Cokkinos, Thyroid hormone and phenotypes of cardioprotection, Basic Res Cardiol 99, 101–120 (2004).

    Article  CAS  PubMed  Google Scholar 

  28. C. Pantos, V. Malliopoulou, I. Mourouzis, E. Karamanoli, S. M. Tzeis, H.C. Carageorgiou, D.D. Varonos, D.V. Cokkinos, Long-term thyroxine administration increases Hsp70 mRNA expression and attenuates p38MAP kinase activity in response to ischemia, J Endocrinol 170, 207–215 (2001).

    Article  CAS  PubMed  Google Scholar 

  29. C. Pantos, V. Malliopoulou, I. Mourouzis, E. Karamanoli, I. Paizis, N. Steinberg, D.D. Varonos, D.V. Cokkinos, Long-term thyroxine administration protects the heart in a similar pattern as ischemic preconditioning, Thyroid 12, 325–329 (2002).

    Article  CAS  PubMed  Google Scholar 

  30. C. Pantos, V. Malliopoulou, I. Paizis, P. Moraitis, I. Mourouzis, S. Tzeis, E. Karamanoli, D. D. Cokkinos, H.C. Carageorgiou, D.D. Varonos, D.V. Cokkinos, Thyroid hormone and cardioprotection; study of p38 MAPK and JNKs during ischemia and at reperfusion in isolated rat heart, Mol Cell Biochem 242, 173–180 (2003).

    Article  CAS  PubMed  Google Scholar 

  31. J. Zhao, O. Renner, L. Wightman, P. H. Sugden, L. Stewart, A. D. Miller, D S. Latchman, M. S. Marber, The expression of constitutively active isotypes of protein kinase C to investigate preconditioning, J Biol Chem 273 23072–79 (1998).

    Article  CAS  PubMed  Google Scholar 

  32. D. Salter, C. Dyke, A. Wechsler, Triodothyronine (T3) and cardiovascular therapeutics: a review, J Card Surg 4, 363–374 (1992).

    Google Scholar 

  33. P. Moruzzi, E. Doria, P. G. Agostoni, V. Capacchione, P. Saganzerla. Usefulness of L-thyroxine to improve cardiac, and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol 73, 374–378 (1994).

    Article  CAS  PubMed  Google Scholar 

  34. P. Moruzzi, E. Doria, P. G. Agostoni, Medium term effectiveness of 1-thyroxine treatment in idiopathic dilated carrdiomyopathy, Am J Med 101, 461–467 (1996).

    Article  CAS  PubMed  Google Scholar 

  35. M. A. Hamilton, L. W. Stevenson, G. C. Fonarow, Safery and hemodynamic effect of intravenous triiodothyronine in advanced congestive heart failure, Am J Cardiol 81, 443–447 (1998).

    Article  CAS  PubMed  Google Scholar 

  36. K. W. Mahaffay, T. Raya, G. Pennock, E. Morkin, S. Goldman, Left ventricular performance and remodelling in rabbits after myocardial infarction: effects of a thyroid hormone analogue, Circulation 91, 794–801 (1995).

    Google Scholar 

  37. K. Ojamaa, A. Kenessey, R. Shenoy, I. Klein, Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat, Am J Physiol Endocrinol Metab 279, E1319–1324 (2000).

    CAS  PubMed  Google Scholar 

  38. L. Friberg, V. Drvota, A. H. Bjelak, Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction, Arch Intern Med 162 1388–94 (2002).

    Article  CAS  PubMed  Google Scholar 

  39. G. Iervasi, A. Pinagitore, P. Landi, M. Raciti, A. Ripoli, M. Scarlattini, A. L’Abbate, L. Donato, Low T3 syndrome, Circulation 107, 708–713 (2003).

    Article  PubMed  Google Scholar 

  40. M. A. Hamilton, L. W. Stevenson, M. Luu, J. A. Walden, Altered thyroid hormone metabolism in advanced heart failure, J Am Coll Cardiol 16, 91–95 (1990).

    CAS  PubMed  Google Scholar 

  41. D. Psirropoulos, N. Lefkos, F. Boudonas, A. Efthimiadis, V. Vogas, C. Keskilidis, G. Tsapas, Heart failure accompanied by sick euthyroid syndrome and exercise training, Curr Opinion Cardiol 17, 266–70 (2002).

    Article  CAS  Google Scholar 

  42. Y. Suzuki, M. Nanno, R. Gemma, T. Yoshimi, Plasma free fatty acids, inhibitor of extrathyroidal conversion of T4 to T3 and thyroid hormone binding inhibitor in patients with various nonthyroidal illness,Endocrinol Jpn 39, 445–53 (1992).

    CAS  PubMed  Google Scholar 

  43. D. Novitzky, P. A. Human, D. K. Cooper, Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs, Ann Thorac Surg 45, 50–55 (1988).

    Article  CAS  PubMed  Google Scholar 

  44. F. G. Spinale, Cellular and molecular therapeutic targets for treatment of contractile dysfunction after cardioplegic arrest, Ann Thorac Surg 68, 1934–41 (1999).

    Article  CAS  PubMed  Google Scholar 

  45. A. Mackie, K. Booth, J. Newburger, et al, A randomized, double-blinded, placebo-controlled trial of triiodothyronine in neonatal heart surgery (Abstr.), J Am Coll Cardiol 45, 321A (2005).

    Article  Google Scholar 

  46. T. Kimura, T. Kanda, A. Kuwabara, H. Shinohara, I. Kobayashi, Participation of the pituitary-thyroid axis in the cardiovascular systemic elderly patients with congestive heart failure, J Med 28, 75–80 (1997).

    CAS  PubMed  Google Scholar 

  47. C. Pantos, V. Malliopoulou, I. Mourouzis, E. Karamanoli, P. Moraitis, S. Tzeis, I. Paizis, H. Carageorgiou, D. Varonos, D. V. Cokkinos, Thyroxine pre-treatment increases basal myocardial Hsp27 expression and accelerates translocation and phosphorylation of this protein upon ischemia, Eur J Pharmacol 478, 53–60 (2003).

    Article  CAS  PubMed  Google Scholar 

  48. F. Chen, R. Chang, M. Trivedi, Y. Capetanaki, V. L. Cryns, Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis, J Biol Chem 278, 6848–53 (2003).

    Article  CAS  PubMed  Google Scholar 

  49. H. L. Blumgart, A. S. Freedberg, G. S. Kurland, Radioactive iodine treatment of angina pectoris and congestive heart failure, Circulation 16, 110–18 (1957).

    CAS  PubMed  Google Scholar 

  50. J. P. Stroraasli, E. L. Schoeniger, H. K. Hellerstein, H. L. Friedell, Thyroid ablation with I113 in euthyroid cardiac patients with special reference to preparation with antithyroid drugs, Radiology 4, E10–21 (1960).

    Google Scholar 

  51. M. Gomberg-Maitland, W. H. Frishman, Thyroid hormone and cardiovascular disease, Am Heart J 135, 187–196 (1998).

    Article  CAS  PubMed  Google Scholar 

  52. I. Klein, K. Ojamaa, Thyroid hormone and the cardiovascular system, N Engl J Med 344, 501–509 (2001).

    Article  CAS  PubMed  Google Scholar 

  53. J. Lekakis, C. Papamichael, M. Alevizaki, G. Piperingos, P. Marafelia, J. Mantzos, S. Stamatelopoulos, D. A. Koutras, Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values, Thyroid 7, 411–4 (1997).

    Article  CAS  PubMed  Google Scholar 

  54. C. I. Pantos, V. Tzilalis, S. Giannakakis, D. D. Cokkinos, S. M. Tzeis, V. Malliopoulou, I. Mourouzis, P. Asimakopoulos, H.C. Carageorgiou, D.D. Varonos, D.V. Cokkinos, Phenylephrine induced aortic vasoconstriction is attenuated in hyperthyroid rats, Int Angiol 20, 181–186 (2001).

    CAS  PubMed  Google Scholar 

  55. C. Pantos. V. Malliopoulou, I. Mourouzis, K. Sfakianoudis, S. Tzeis, P. Doumba, C. Xinaris, A.D. Cokkinos, H.C. Carageorgiou, D.D. Varonos, D.V. Cokkinos, Propylthiouracil induced hypothyroidism is associated with increased tolerance of the isolated rat heart to ischemia-reperfusion, J Endocrinol 17 8, 427–735 (2003).

    Article  CAS  PubMed  Google Scholar 

  56. C. Pantos, I. Mourouzis, V. Malliopoulou, I. Paizis, S. Tzeis, P. Moraitis, K. Sfakianoudis, D.D. Varonos, D.V. Cokkinos, Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: A Possible involvement of thyroid hormone receptor α1. Thyroid 15, 16–23 (2005).

    Article  CAS  PubMed  Google Scholar 

  57. R.-G. Shi, J.-K. Lee, Y. Takeuchi, M. Horiba, F. Kambe, H. Sea, I Murata, I Kodama, Remodeling of T3-responsive gene transcription in rat hearts by chronic amiodarone (Abstr), Circulation 10, III–99 (2004).

    Google Scholar 

  58. C. S. Apstein, P. Menasche, B. H. Lorell, Hypoxia, ischemia, and the hypertrophied myocardium: basic medical and surgical considerations. In: Cardiac hypertrophy and failure. Swynghedauw B, ed. Editions INSERM, Paris pp 65–87 (1990).

    Google Scholar 

  59. L. F. Wexler, B. H. Lorell, S. Momomura, E. O. Weinberg, J. S. Ingwall, C. S. Apstein, Enhanced sensitivity to hypoxia-induced diastolic dysfunction in pressure-overload left ventricular hypertrophy in the rat: role of high-energy phosphate depletion, Circ Res 62, 766–75 (1988).

    CAS  PubMed  Google Scholar 

  60. S. Koyanagi, C. L. Eastham, D. G. Harrison, M. L. Marcus, Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy, Circ Res 50, 55–62 (1982).

    CAS  PubMed  Google Scholar 

  61. D. A. Cooley, G. J. Reul, D. C. Wukash, Ischemic contracture of the heart “stone heart”, Am J Cardiol 29, 575–77 (1972).

    Article  CAS  PubMed  Google Scholar 

  62. J. Schaper, F. Schwarz, W. Flameng, F. Hehrlein, Tolerance to ischemia of hypertrophied human hearts during valve replacement, Basic Res Cardiol 73, 171–87 (1978).

    Article  CAS  PubMed  Google Scholar 

  63. M. L. Marcus, S. Koyanagi, D. G. Harrison, D. B. Doty, L. F. Hiratzka, C. L. Eastham, Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy, Am J Med 1983;75:62–66.

    Article  CAS  PubMed  Google Scholar 

  64. M. E. Speechly-Dick, G. F. Baxter, D. M. Yellon, Ischemic preconditioning protects hypertrophied myocardium, Cardiovasc Res 8, 1025–1029 (1994).

    Google Scholar 

  65. C. I. Pantos, C. H. Davos, H. C. Carageorgiou, D. V. Varonos, D. V. Cokkinos, Ischemic preconditioning protects against myocardial dysfunction caused by ishaemia in isolated hypertrophied rat hearts, Basic Res Cardiol 91, 444–449 (1996).

    Article  CAS  PubMed  Google Scholar 

  66. J. A. Moolman, S. Genade, E. Tromp, L. H. Opie, A. Lochner, Ischemic preconditioning does not protect hypertrophied myocardium against ischemia, S Afr Med J 87, C151–6 (1997).

    PubMed  Google Scholar 

  67. C. Pantos, I. Mourouzis, S. Tzeis, V. Malliopoulou, D. D. Cokkinos, Asimakopoulos, H.C. Carageorgiou, D.D. Varonos, D.V. Cokkinos, Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts, J Cardiovasc Pharmacol 36, 384–389 (2000).

    Article  CAS  PubMed  Google Scholar 

  68. K. C. Chang, V. M. Figueredo, J. H. M. Schreur, K. Kariya, M. W. Weiner, P. C. Simpson, S. A. Camacho, Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts, J Clin Invest 100, 1742–1749 (1997).

    Article  CAS  PubMed  Google Scholar 

  69. T. Miki, T. Miura, A. Tsuchiada, A. Nakano, T. Hasegawa, T. Fukuma, K. Shimamoto, Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type receptor activation, Circulation 102, 458–63 (2001).

    Google Scholar 

  70. S. Ghosh, N. B. Standen, M. Galinanes, Failure to precondition pathological human myocardium, J Am Coll Cardiol 37, 711–8 (2001).

    Article  CAS  PubMed  Google Scholar 

  71. L. R. Dekker, H. Rademaker, J. T. Vermeulen, T. Opthof, R. Coronel, J. A. Spaan, M. J. Janse,. Cellular uncoupling during ischemia in hypertrophied and failing rabbit ventricular myocardium: effects of preconditioning, Circulation 97, 1724–30 (1998).

    CAS  PubMed  Google Scholar 

  72. A. Efstathiou, S. Seraskeris, C. Papakonstantinou, A. Aidonopoulos, A. Lazou, Differential effect of preconditioning on post-ischemic myocardial performance in the absence of substantial infarction and in extensively infarced rat hearts, Eur J Cardiothorac Surg 19, 493–499 (2001).

    Article  CAS  PubMed  Google Scholar 

  73. T. Shimohama, Y. Suzuki, C. Noda, H. Niwano, K. Sato, T. Masuda, K. Kawahara, T. Izumi, Decreased expression of Na+/H+ exchanger isoform 1 (NHE1) in non-infarced myocardium after acute myocardial infarction, Jpn Heart J 3, 273–82 (2002).

    Article  Google Scholar 

  74. R. J. Diaz, G. J. Wilson, Modifying the first minute of reperfusion: potential for myocardial salvage. Editorial, Cardiovasc Res 62, 4–6 (2004).

    Article  CAS  PubMed  Google Scholar 

  75. H. Kin, Z.-Q. Zhao, H.-Y. Sun, N.-P. Wang, J. S. Cowera, M. E. Halkos, F. Kerandi, R. A. Guyton, J. Vinten-Johansen, Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion, Cardiovasc Res 62, 9–85 (2004).

    Article  CAS  Google Scholar 

  76. H. S. Mickel, Y. K. Vaishnav, O. Kempski, D. von Lubitz, J. F. Weiss, G. Feuerstein, Breathing 100% oxygen after global brain ischemia in Mongolian gerbils redults in increased lipid peroxidation and increased mortality, Shoke 18, 426–30 (1987).

    CAS  Google Scholar 

  77. H. M. Piper, Y. Abdallah, C. Schofer, The first minutes of reperfusion: a window of opportunity for cardioprotection, Cardiovasc Res 61, 365–71 (2004).

    Article  CAS  PubMed  Google Scholar 

  78. J. Inerte, D. Garcia-Dorado, M. Ruiz-Meana, F. Padilla, JA. Barrabes, P. Pina. L. Agullo, H. M. Piper, J. Soler-Soler, Effect of inhibition of Na+/Ca2+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death, Cardiovasc Res 55, 739–48 (2002).

    Article  Google Scholar 

  79. H. H. Klein, S. Pich, R. M. Bohle, J. Wollenweber, K. Nebendahl, Na+/H+ exchange inhibitor caripovide attenuates cell injury precominantly during ischemic and not on onset of reperfusion in porcine hearts with low residual blood flow, Circulation 92, 912–7 (1995).

    CAS  PubMed  Google Scholar 

  80. U. Zeymer, H. Suryapranata, J. P. Monassier, G. Opolski, J. Davies, G. Rasmanis, G. Linssen, U. Tebbe, R. Schroder, R. Tiemann, T. Machnig, K.L. Neuhaus; ESCAMI Investigators, The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safery and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI trial), J Am Coll Cardiol 38, 645–50 (2001).

    Article  Google Scholar 

  81. C. Weinbrenner, G. S. Liu, J. M. Downey, M. V. Cohen, Cyclosporine A limits infarct size even when administered after onset of ischemia, Cardiovasc Res 38, 678–84 (1998).

    Article  CAS  PubMed  Google Scholar 

  82. A. Hempel, M. Friedrich, K. D. Schóter, W. G. Forssmann, M. Kuhn, H. M. Piper, ANP protects against reoxygenation-induced hypercontracture in adult cardiomyocytes, Am J Physiol 273, H244–9 (1997).

    CAS  PubMed  Google Scholar 

  83. F. Padilla, D. Garcia-Doprado, L. Agullo, J. A. Barrabes, J. Inserte, N. Escalona, M. Meyer, M. Mirabet, P. Pina, J. Soler-Soler, Intravenous administration of the natriuretic pepride urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs, Cardiovasc Res 51. 592–600 (2001).

    Article  CAS  PubMed  Google Scholar 

  84. M. N. Sack, D. M. Yellon, Insulin therapy as an adjunct to reperfusion after acute coronary ischemia proposed direct myocardial cell survival effect independent of metabolic modulation, J Am Coll Cardiol 41, 1404–7 (2003).

    Article  CAS  PubMed  Google Scholar 

  85. U. Fischer-Rasokat, F. Beyersdorf, T. Doenst, Insulin addition after ischemia improves recovery of function equal to ischemic preconditioning in rar heart, Basic Res Cardiol 8, 329–36 (2003).

    Article  CAS  Google Scholar 

  86. R. M. Bell, D. M. Yellon, Atorvastatin administered at the onset of reperfusion, and independently of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway, J Am Coll Cardiol 41, 508–15 (2003).

    Article  CAS  PubMed  Google Scholar 

  87. S. Verma, P. Fedak, R. D. Weisel, J. Butany, V. Rao, A. Maitland, R.-K. Li, B. Dhillon, and T. M. You, Fundamentals of reperfusion injury for the clinical cardiologist, Criculation 105, 2332–36 (2002).

    Article  Google Scholar 

  88. O. Turschner, J. Dlooge, C. Dommke, P. Claus, E. Verbeken, I. De Scheerder, B. Bijnens, and G. R. Sutherland, The sequential changes in myocardial thickness and thickening which occur during acute transmural infarction, infarct reperfusion and the resultant expression of reperfusion injury, Eur Heart J 25, 794–803 (2004).

    Article  PubMed  Google Scholar 

  89. I. Tritto, D. D’Andrea, N. Eramo, A. Scognamiglio, C. De Simone, A. Violante, A. Esposito, M. Chiariello, G Ambrosio, Oxygen radicals can induce preconditioning in rabbit hearts, Circ Res 80, 743–748 (1997).

    CAS  PubMed  Google Scholar 

  90. D. X. Zhang, Y.-F. Chen, W. B. Campbell, A.-P. Zou, G. J. Gross, P.-L. Li, Characteristics and super-oxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels, Circ Res 89, 177–83 (2001).

    Google Scholar 

  91. J. Huot, F. Houle, F. Marceau, J. Landry, Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinasekeat shock protein 27 pathway in vascular endothelial cells, Circ Res 80, 383–392 (1997).

    CAS  PubMed  Google Scholar 

  92. X. L. Tang, H. Takano, A. Rizvi, J. F. Turrens, Y. Qiu, W. J. Wu, Q. Zhang, R. Bolli, Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits, Am J Physiol Heart Circ Physiol 282, H281–91 (2002).

    CAS  PubMed  Google Scholar 

  93. K. D. Garlid, Opening mitochondrial KATP in the heart-what happens, and what does not happen, Basic Res Cardiol 95, 275–279 (2000).

    Article  CAS  PubMed  Google Scholar 

  94. R. A. Forbes, C. Steenbergen, E. Murphy, Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism, Circ Res 88, 802–09 (2001).

    CAS  PubMed  Google Scholar 

  95. E. Roth, M. T. Jaberansari, Reactive oxygen species in early and delayed cardiac adaptation, Exp Clin Cardiol 6, 81–86 (2001).

    CAS  PubMed  Google Scholar 

  96. C. S. Can; D. Yellon, Ischemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle, Basic Res Cardiol 92, 252–60 (1997).

    Article  Google Scholar 

  97. J. Minners, E. J. van den Bos, D. M. Yellon, H. Schwalb, L. H. Opie, M. N. Sack, Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection, Cardiovasc Res 47, 68–73 (2000).

    Article  CAS  PubMed  Google Scholar 

  98. A. N. Khatkevich, S. N. Dvoryantsev, V. Kapelko, E. K. Ruuge, The protective effect of ischemic preconditioning depends on the duration of prolonged ischemia, Exp Clin Cardiol 4, 186–190 (1999).

    CAS  Google Scholar 

  99. M. V. Cohen, J. M. Downey. Ischemic preconditioning: can the protection be bottled? Lancet 342, 8862–66 (1998).

    Google Scholar 

  100. R. N. MacAlpin, A. A. Kattus, Adaptation to exercise in angina pectoris, Circulation 33, 183–201 (1966).

    Google Scholar 

  101. F. Tomai, Warm up phenomenon and preconditioning in clinical practice, Heart 87, 91–100 (2002).

    Article  Google Scholar 

  102. Y. Okazaki, K. Kodama, H. Sato, M. Kitakaze, A. Hirayama, M. Mishima, M. Hori, M. Inoue, Attenuation of increased regional myocardial consumption during exercise as a major cause of warm-up phenomenon, J Am Coll Cardiol 21, 1597–604 (1993).

    CAS  PubMed  Google Scholar 

  103. N. Yamashita, S. Hoshida, K. Otsu, M. Asahi, T. Kuzuya, M. Hori, Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation, J Exp Med 189, 699–1706 (1999).

    Article  Google Scholar 

  104. P. D. Lambiase, R. J. Edwards, M. R. Cusack, C. A. Bucknall, S. R. Redwood, M. S. Marber, Exercise — induced ischemia initates the second window of protection in humans independent of collateral recruitment, J Am Coll Cardiol 41, 1174–82 (2003).

    Article  PubMed  Google Scholar 

  105. A. D. Kelion, T. P. Webb, M. A. Gardner, The warm-up effect protects against ishcemic left ventricular dysfunction in patients with angina, J Am Coll Cardiol 37, 705–10 (2001).

    Article  CAS  PubMed  Google Scholar 

  106. M. S. Marber, D. S. Latchman, J. M. Walker, D. M. Yellon, Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with assistance to myocardial infarction, Circulation 88, 1264–72 (1993).

    CAS  PubMed  Google Scholar 

  107. N. Maulik, R. M. Engelman, Z. Wei, X. Liu, J. A. Rousou, J. E. Flack, D. Deaton, D. K. Das, Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2, Circulation 100, II-369–75 (1999).

    CAS  Google Scholar 

  108. E. Deutsch, M. Berger, W. G. Kussmaul, J. W. Hirshfeld, H. C. Herrmann, W. L. Laskey, Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical hemodynamic and metabolic features, Circulation 82, 044–51 (1990).

    Google Scholar 

  109. A. Cribier, L. Korsatz, R. Koning, P. Path, H. Gamra, G. Stix, S. Merchant, C. Chan, B. Letac, Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty, J Am Coll Cardiol 20, 578–586 (1992).

    CAS  PubMed  Google Scholar 

  110. L. W. Klein, M. J. Kern, P. Berger, T. Sanborn, P. Block, J Babb, C. Tommaso, J. M. Hodgson, T. Feldman, Society of cardiac angiography and interventions; suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory, Catheter Cardiovasc Interv 60, 194–201 (2003).

    Article  PubMed  Google Scholar 

  111. K. Przyklenk, B. Bauer, M. Ovize, R. A. Kloner, P. Whittaker, Regional ischemic preconditioning protects remote virgin myocardium from subsequent sustained coronary occlusion, Circulation 87, 893–899 (1993).

    CAS  PubMed  Google Scholar 

  112. Y. Birnbaum, S. L. Hale, R. A. Kloner, Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit, Circulation 96, 641–6 (1997).

    Google Scholar 

  113. K. Przyklenk, C. E. Darling, E. W. Dickson, P. Whittaker, Cardioprotection “outside the box”, Basic Res Cardiol 98, 149–57 (2003).

    PubMed  Google Scholar 

  114. I. Sheiban, S. Tonni, P. Benussi, A. Marini, G.P. Trevi, Left ventricular dysfunction following transient ischemia induced by transluminal coronary angioplasty, Eur Heart J 4,(Suppl A): 14–21 (1993).

    Google Scholar 

  115. D. M. Yellon, A. M. Alkulaifi, W. B. Pugsley, Preconditioning the human myocardium, Lancet 42, 276–277 (1993).

    Article  Google Scholar 

  116. D. P. Jenkins, W. B. Pugsley, M. Kemp, J. Hooper, D. M. Yellon, Ischemic preconditioning reduces troponin-T release in patients undergoing cardiac surgery, Heart 77, 14–318 (1997).

    Google Scholar 

  117. P. Szmagala, K. T. Gbure, N. Morawski, et al, A clinical assessment of ischemic preconditioning for aorto-coronary bypass surgery, Cor Europaeum 7, 107–111 (1999).

    Google Scholar 

  118. R. Gray, J. Maddhai, D. Berman, M. Raymond, A. Waxman, W. Ganz, J. Matloff, H. J. C. Swan, Scintigraphic and hemodynamic demonstration of transient left ventricular dysfunction immediately after uncomplicated coronary artery bypass grafting, J Thorac Cardiovasc Surg. 77, 504–10 (1979).

    CAS  PubMed  Google Scholar 

  119. D. T. Mangano, Biventricular function after myocardial revascularization in humans. Deterioration and recovery patterns during the first 24 hours, Anesthesiology 62, 571–577 (1985).

    CAS  PubMed  Google Scholar 

  120. C. M. Ballantyne, M. S. Verani, H. D. Short, C. Hyatt, G. P. Noon, Delayed recovery of severely “stunned” myocardium with the support of a left ventricular assist device after coronary artery bypass graft surgery, J Am Coll Cardiol 10, 710–712 (1987).

    CAS  PubMed  Google Scholar 

  121. L. Czer, A. Hamer, F. Murphy, J. Bussell, A. Chaux, T. Bateman, J. Matloff, R. J. Gray, Transient hemodynamic dysfunction after myocardial revascularization, J Thorac Cardiovasc Surg 86, 226–234 (1983).

    CAS  PubMed  Google Scholar 

  122. S. Verma, P. W. Fedak, R. D. Weisel, P. E. Szmitko, M. V. Badiwala, D. Bonneau, D. Latter, L. Errett, Y. LeClerc, Off-pump coronary artery bypass surgery: fundamentals for the clinical cardiologist, Circulation 109, 1206–11 (2004).

    Article  PubMed  Google Scholar 

  123. C. P. Baines, J. M. Pass, P. Ping, Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning, Basic Res Cardiol 96, 207–218 (2001).

    Article  CAS  PubMed  Google Scholar 

  124. G. S. Liu, J. Thomton, D. M. van Winkle, A. W. H. Stanely, R. A. Olsson, J. M. Downey, Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart, Circulation 84, 350–6 (1991).

    CAS  PubMed  Google Scholar 

  125. A. Dana, M. Skarli, J. Papakrivopoulou, D. M. Yellon, Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-actibated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase and protein kinase C-dependent mechanism, Circ Res 86, 921–2 (2000).

    Google Scholar 

  126. T. C. Zhao, D. S. Hines, R. C. Kukreja, Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial KATP channels, Am J Physiol Heart Circ Physiol 280, H1278–85 (2001).

    CAS  PubMed  Google Scholar 

  127. U. E. Heidland, M. P. Heintzen, B. Schwartzkopff, B. E. Strauer, Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosine, Am Heart J 140, 813–20 (2000).

    Article  CAS  PubMed  Google Scholar 

  128. M. A. Leesar, M. Stoddard, M. Ahmed, J. Broadbent, R. Bolli, Preconditioning of human myocardium with adenosine during coronary angioplasty, Circulation 95, 2500–7 (1997).

    CAS  PubMed  Google Scholar 

  129. M. J. Claeys, C. J. Vrints, J. M. Bosmans, V. M. Conraads, J. P. Snoeck, Aminophylline inhibits adaptation to ischemia during angioplasty, Eur Heart J 17, 539–44 (1996).

    CAS  PubMed  Google Scholar 

  130. M. Quintana, T. Kahan, P. Hjemdahl, Pharmacological prevention of reperfusion injury in acute myocardial infarction, A potential role for adenosine as a therapeutic agent. Am J Cardiovasc Drugs 4, 159–67 (2004).

    Article  CAS  PubMed  Google Scholar 

  131. V. H. Thourani, R. S. Ronson, D. G. L van Wylen, S. T. Shearer, S. L. Katzmark, Z.-Q. Zhao, D. C. Han, RA Guyton, J. Vinten-Johansen, Adenosine-supplemented blood cardioplegia attenuates postischemic dysfunction after severe regional ischemia, Circulation 100, II 376–83 (1999).

    CAS  Google Scholar 

  132. Z. Yao, G. J. Gross, Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium, Circulation 88, 235–44 (1993).

    CAS  PubMed  Google Scholar 

  133. G. J. Grover, A. J. D’Alonzo, S. Dzwonczyk, C. S. Parham, R. B. Darbenzio, Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide, Am J Physiol 271, H1207–HI214 (1996).

    CAS  PubMed  Google Scholar 

  134. K. D. Garlid, P. Paucek, V. Yarov-Yarovoy, H. N. Murray, R. B. Darbenzio, A. J. D’Alonzo, N. J. Lodge, M. A. Smith, G. J. Grover, Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels, Possible mechanism of cardioprotection, Circ Res 81, 1072–1082 (1997).

    CAS  PubMed  Google Scholar 

  135. K. D. Garlid, P. Paucek, B. Yarov-Yarovoy, H. N. M. Murray, R. B. Darbenzio, A. J. D’Alonzo, N..J. Lodge, M. A. Smith, G. J. Grover, Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive potassium channels: possible mechanism of cardioprotection, Circ Res 1, 1072–1082 (1997).

    Google Scholar 

  136. G. Grover, J. Newburger, P. Sleph, S. Dzwonczyk, S. Taylor, S. Ahmed, K. Atwal, Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides, J Pharmacol Exp Ther 257, 156–162 (1991).

    CAS  PubMed  Google Scholar 

  137. G. J. Grover, K. D. Garlid. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32, 677–695 (2000).

    Article  CAS  PubMed  Google Scholar 

  138. Y. Liu, T. Sato, B. O’Rourke, E. Marban, Mitochondrial KATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97, 2463–2469 (1998).

    CAS  PubMed  Google Scholar 

  139. J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, E. Delpon, Pharmacology of cardiac potassium channels, Cardiovasc Res 62, 9–33 (2004).

    Article  CAS  PubMed  Google Scholar 

  140. J. C. Cleveland, D. R. Meldrum, V. S. Cain, A. Banerjee, A. Harken, Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited, Circulation 96, 29–32 (1997).

    CAS  PubMed  Google Scholar 

  141. P. Brady, A. Terzie, The sulfonylurea controversy: more questions from the heart, J Am Coll Cardiol 131, 950–6 (1998).

    Article  Google Scholar 

  142. B. O’Rourke, Mitochondrial KATP channels in preconditioning, Circ Res 87, 845–855 (2000).

    CAS  PubMed  Google Scholar 

  143. J. A. Auchampach, M. Maruyama, G. J. Gross, Cardioprotective actions of potassium channel openers, Eur Heart J 15, 81–84 (1994).

    Google Scholar 

  144. F. Tomai, F. Crea, A. Gaspardone, F. Versaci, R. De Paulis, A. Penta de Peppo, L. Chiariello, P.A. Gioffre, Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker, Circulation 90, 700–5 (1994).

    CAS  PubMed  Google Scholar 

  145. M. M. Mocanu, H. L. Maddock, G. F. Baxter, C. L. Lawrence, N. B. Standen, D. M. Yellon, Glimepiride, a Novel Sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning of diazoxide, Circulation 103, 111–3116 (2001).

    Google Scholar 

  146. H. Klepzig, G. Kobet C. Matter, H. Luus, H. Scheneider, K. H. Boedeker, W. Kiowski, Amman, F. W. D. Gruber, S. Hams, W. Burger, Sulfonylureas and ischemic preconditioning, Eur Heart J 20, 439–46 (1999).

    Article  CAS  PubMed  Google Scholar 

  147. T. Matsubara, S. Minatoguchi, H. Matsuo, K. Hayakawa, T. Segawa, Y. Matsuno, S. Watenabe, M. Arai, Y. Uno, M. Kawasaki, T. Noda, G. Takemura, K. Nishigaki, H. Fujiwara, Three minutes, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease, J Am Coll Cardiol 35, 345–51 (2000).

    Article  CAS  PubMed  Google Scholar 

  148. N. Taira, Nicorandil as a hybrid between nitrates and potassium channel activators, Am J Cardiol 3, 185–245 (1989).

    Google Scholar 

  149. E. K. Iliodromitis, P. Cokkinos, A. Zoga, I. Steliou, A. R. Vrettou, D. T. Kremastinos, Nicorandil recaptures the waned protection from preconditioning in vivo, Br J Phannacol 138, 1101–06 (2003).

    Article  CAS  Google Scholar 

  150. T.-M. Lee, S.-F. Su, T.-F. Chou, Y. T. Lee, C.-H. Tsai, Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty, Circulation 105, 334–40 (2002).

    Article  CAS  PubMed  Google Scholar 

  151. The IONA study group. Effect of nicorandil on coronary events in patients with stable angina: The impact of Nicorandil in Angina (IONA) randomized trial, Lancet 359, 1269–7 (2002).

    Article  Google Scholar 

  152. M. Buerke, H.-J. Rupprecht, J. vom Dahl, W. Terres, M. Seyfurth, H.-P. Schultheiss, G. Richardt, F. H. Sheehan, H. Dexlet, Sodium-hydrogen exchange inhibition: Novel strategy to prevent myocardial injury following ischemia and reperfusion, Am J Cardiol 83, 19G–22G (1999).

    Article  CAS  PubMed  Google Scholar 

  153. M. Hill, H. Takano, X.-L. Tang, E. Kodani, G. Shirk, R. Bolli, Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance, Circulation 104, 694–699 (2001).

    CAS  PubMed  Google Scholar 

  154. M. A. Leesar, M. F. Stoddard, B. Dawn, V. G. Jasti, R. Masden, R Bolli, Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty, Circulation 103, 2935–2941 (2001).

    CAS  PubMed  Google Scholar 

  155. G. Heusch, Nitroglycerin and delayed preconditioning in humans, Circulation 103, 2876–2878 (2001).

    CAS  PubMed  Google Scholar 

  156. D. Hasdai, S. Behar, L. Wallentin. N. Danchin, A. K. Gitt, E. Boersma, P. M. Fioretti, M. L. Simoons, A. Battler, A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin, Eur Heart J 23, 1190–1201 (2002).

    Article  CAS  PubMed  Google Scholar 

  157. E. Sbarouni, E. K. Iliodromitis, E. Bofilis, Z. S. Kyriakides, D. T. Kremastinos, Short-term estrogen reduces myocardial infarct size in oophororectomized female rabbits in a dose-dependent manner, Cardiovasc Drugs Ther 12, 45742 (1998).

    Article  Google Scholar 

  158. E. Sbarouni, E. K. Iliodromitis, E. Bofilis, ZS. Kyriakides, D. T. Kremastinos, Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size, Eur J Pharmacol 467, 163–8 (2003).

    Article  CAS  PubMed  Google Scholar 

  159. H. Ogita, K. Node, H. Asanuma, S. Sanada, Y. Liao, S. Takashima, M. Asakura, H. Mori, Y. Shizonaki, M. Hori, M. Kitakazo, Amelioration of ischemia and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart, JAm Coll Cardol 40, 998–1005 (2002).

    Article  CAS  Google Scholar 

  160. K. M. English, R. D. Jones, T. H. Jones, A. H. Morice, K. S. Channer, Testosterone acts as a coronary vasodilator by a calcium antagonistic action, J Endocrinol Invest 25, 455–8 (2002).

    CAS  PubMed  Google Scholar 

  161. F. Callils, H. Stromer, R. H. Schwinger, B. Bolck, K. Hu, S. Frantz, A. Leupold, S. Beet, B. Allolio, A. M. Bonz, Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia, Endocrinology 144, 4478–83 (2003).

    Article  CAS  Google Scholar 

  162. F. Er, G. Michels, N. Gassanov, F. Rivero, U. C. Hope, Testosterone induces cytoprotection by activating K+ channels in the cardiac mitochondrial inner membrane, Circulation 110, 3100–07 (2004).

    Article  CAS  PubMed  Google Scholar 

  163. JF. Reckelhoff, Sex steroids, cardiovascular disease, and hypertension, Hypertension 45, 170–4 (2005).

    Article  CAS  PubMed  Google Scholar 

  164. R. B. Melchert, A. A. Weider. Cardiovascular effects of androgenic anabolic steroids. Med Sci Sports Exerc 7, 1252–62 (1995).

    Google Scholar 

  165. T. V. Pham, E. A. Sosunov, E. P. Anyukhorsky, P Jr Danilo, M. R. Rosen, Testosterone diminishes the proarrhythrnic effects of dofetilide in normal female rabbits, Circulation 06, 21324 (2002).

    Google Scholar 

  166. B. K. Podesser, J. Schirnhofer, 0. Y. Bernecker, A. Kroner, M. Franz, S. Semsroth, B. Fellner, J. Neumoller, S. Hallstrom, and E. Wolner, Optimizing ischemia/reperfusion in the failing rat heart-improved myocardial protection with acute ACE inhibition, Circulation 106,Suppl I:277–283 (2002).

    Google Scholar 

  167. M. Sato, R. M. Engelman, H. Otani, N. Maulik, J. Rousou, J. Flack, D. W. Deaton, D. K. Das, Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker. Implication of bradykinin-dependent and bradykinin-independent mechanisma, Circulation 120,sup1III: III-346–III-351 (2000).

    Google Scholar 

  168. M. Leesar, M. F. Stoddard, S. Manchikalapudi, R. Bolli, Bradykinin-induced preconditioning in patients undergoing coronary angioplasty, JAm Coll Cardiol 34, 639–50 (1999).

    Article  CAS  Google Scholar 

  169. G. Valen, S. Takeshima, M. Ahmad, J. Zeitlin, J. Parratt, J. Baage, Bradykinin in open heart surgery: Metabolism of bradykinin in the coronary circulation during reperfusion, Exp Clin Cardiol 2, 223–227 (1997).

    Google Scholar 

  170. E. R. Schwarz, H. Montino, J. Fleischhauer, H. G. Klues, J. vom Dahl, P. Hanrath, Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditionng in the pig heart, Cardiovasc Drugs Ther 11, 687–9 (1997)5.

    Article  CAS  PubMed  Google Scholar 

  171. Y. Nozawa, T. Miura, A. Tsuchida, H. Kita, T. Fukuma, K. Shimamoto, Chronic treatment with an ACE inhibitor, temocapril, lowers the threshold for the infarct size-limiting effect of ischemic preconditioning, Cardiovasc Drugs Ther 13, 151–7 (1999).

    Article  CAS  PubMed  Google Scholar 

  172. M. T. Jaberansari, G. F. Baxter, C. A. Muller, S. E. Latouf, E. Roth, L. H. Opie, D. M. Yellon, Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium, JAm Coll Cardiol 37, 1996–2001 (2001).

    Article  CAS  Google Scholar 

  173. B. Bartling, I. Friedrich, R. E. Silber, A. Simm, Ischemic preconditioning is not cardioprotective in senescent human myocardium, Ann Thorac Surg 76, 105–11 (2003).

    Article  PubMed  Google Scholar 

  174. K. Hayakawa, G. Takemura, M. Kanoh, Y. Li, M. Koda, Y. Kawase, R. Manvyama, H. Okada, S. Minatoguchi, T. Fujiwara, H. Fujiwara, Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunctio nat the chronic stage, Circulation 108, 104–09 (2003).

    Article  PubMed  Google Scholar 

  175. N. Maulik, R. M. Engelman, J. A. Rousou, J.E. Flack 3rd, D. Deaton, D.K. Das, Ischemic preconditioning reduces apoptosis by upregulating anti-death gene bcl-2, Circulation 100,Suppl II-369–375 (1999).

    CAS  Google Scholar 

  176. C. D. Veronsee, W. R. Lewis, M. W. Takla, E. A. Hull-Ryde, J. E. Lowe, Protective metabolic effects of propranolol during total myocardial ischemia, J Thorac Cardiovasc Surg 92, 425–33 (1986).

    Google Scholar 

  177. A. Cargnoni, C. Ceconi, P. Bernocchi, A. Boraso, G. Parrinello, S. Curello, R. Ferrari, Reduction of oxidative stress by carvedilol: role in maintenance of ischemic myocardium viability, Cardiovasc Res 47, 556–566 (2000).

    Article  CAS  PubMed  Google Scholar 

  178. T. L. Yue, X. L. Ma, R. Gu, R. R. Jr Ruffolo, G. Z. Feuerstein, Carvedilol inhibits activation of stress-activated protein kinase JNK and reduces reperfusion injury in perfused rabbit heart, Eur J Pharmacol 345, 61–5 (1998).

    Article  CAS  PubMed  Google Scholar 

  179. T. Ide, H. Tsutsui, S. Kinugawa, H. Utsumi, A. Takeshita, Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action, Circulation 100, 690–692 (1999).

    CAS  PubMed  Google Scholar 

  180. R. Gasser, G. Frey, G. Fleckenstein-Grón, Y. K. Byon, A. Fleckenstein, Some observations on Ca-overload in rat ventricular tissue, J Clin Basic Cardiol 2, 255–8 (1999).

    CAS  Google Scholar 

  181. M. J. Daly, J. S. Elz, W. G. Nayler, The effect of verapamil on ischemia-induced changes to the sarcolemma, J Mol Cell Cardiol 7, 667–74 (1985).

    Google Scholar 

  182. K. Inagaki, Y. Kihara, T. Izumi, S. Sasayama, The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/heperfusion-induced Ca2+ overload is isolated rat hearts, Cardiovasc Drug Ther 14, 489–95 (2000).

    Article  CAS  Google Scholar 

  183. R. Sato, J. Yamazaki, T. Nagao, Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts, J Pharmacol Exp Ther 89, 831–9 (1999).

    Google Scholar 

  184. D. V. Fitzpatrick, M. Karmazyn, Comparative effects of calcium channel blocking agents and varying extracellular calcium concentration on hypoxidreoxygenation and ischemia/reperfusion-induced cardiac injury, J Pharmacol Exp Ther 28, 761–768 (1984).

    Google Scholar 

  185. K. Herbaczynska-Cedro, W. Gordon-Makszak, Nisoldipine inhibits lipid peroxidation induced by coronary occlusion in pig myocardium, Caridiovasc Res 24, 683–687 (1990).

    CAS  Google Scholar 

  186. A. J. Higgins, K. J. Blackburn, Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists, J Mol Cell Cardiol 16, 127–138 (1984).

    Google Scholar 

  187. W. W. Holt, M. F. Wendland, N. Derugin, C. Wolfe, M. Saeed, C. B. Higgins, Effects of nicardipine, a calcium antagonist, on myocardial salvage and high energy phosphate stores in reperfixed myocardial injury, J Am Coll Cardiol 16, 1736–1744 (1990).

    CAS  PubMed  Google Scholar 

  188. K. Przylenk, R. A. Kloner, Effect of verapamil on postischemic “stunned” myocardium. Importance of the timing of treatment, J Am Coll Cardiol 11, 614–623 (1988).

    Google Scholar 

  189. L. H. Opie, Reperhion injury and its pharmacological modification. Circulation 80, 1049–1062 (1989).

    CAS  PubMed  Google Scholar 

  190. L. H. Opie, Reperfusion injury and calcium antagonists, Cardiologia 35(Suppl 1), 213–221 (1990).

    Google Scholar 

  191. J. S. Garrett, J. Wikman-Coffelt, R. Sievers, W. E. Finkbeiner, W. W. Parmley, Verapamil prevents the development of alcoholic dysfunction in hamster myocardium, J Am Coll Cadiol 9, 1326–31 (1987).

    Article  CAS  Google Scholar 

  192. R. Sievers, W. W. Parmley, T. James, J. Wikman-Coffelt, Energy levels at systole vs diastole in normal hamster hearts vs myopathic hamster hearts, Circ Res 53, 759–66 (1983).

    CAS  PubMed  Google Scholar 

  193. J. J. McVeigh, G. D. Lopaschuk, Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts, Am J Physiol 259, H1079–HI085 (1990).

    CAS  PubMed  Google Scholar 

  194. M. R. Graslinski, S. C. Black, K. S. Kilgore, A. Y. Chou, J. G. McCormack, B. R. Lucchesi, Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart, Cardiovasc Res 28, 1231–1237 (1994).

    Article  Google Scholar 

  195. S. Schmidt-Schweda, C. Holubarsch, First clinical trial with etomoxir in patients with chronic congestive heart failure, Clin Sci 99, 7–35 (1999).

    Google Scholar 

  196. J. M. Detry, P. Sellier, S. Pennaforte, D. Cokkinos, H. Dargie, P Mathes, Trimetazidine: a new concept in the treatment of angina. Comparison with propranolo in patients with stable angina, Br J Clin Phormacol 37, 279–88 (1994).

    CAS  Google Scholar 

  197. J. N. Fabiani, O. Ponzio, I. Emerit, S. Massonet-Castel, M. Paris, P. Chevalier, V. Jebara, A. Carpentier, Cardioprotective effect of trimetazidine during coronary artery graft surgery, J Cardiovasc Surg 3, 486–491 (1992).

    Google Scholar 

  198. S. Schmidt-Schweda, C. Holubarsch, First clinical trial with etomoxir in patients with chronic congestive heart failure, Clin Sci 99, 27–35 (1999).

    Article  Google Scholar 

  199. F. V. Mody, B. N. Singh, I. H. Mohiuddin, K. B. Coyle, D. B. Buxton, H. W. Hansen, R. Sumida, H. R. Schekber, Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: An evaluation by positron emission tomography, Am J Cardiol 82, 42K–49K (1998).

    Article  CAS  PubMed  Google Scholar 

  200. C. Pantos, A. Bescond-Jacket, S. Tzeis, I. Paizis, I. Mourouzis, P. Moraitis, V. Malliopoulou, E.D. Politi, H. Karageorgiou, D. Varonos, D.V. Cokkinos, Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner, Basic Res Cardiol 100(2), 154–160 (2005).

    Article  CAS  PubMed  Google Scholar 

  201. T. L. Broderick, A. Quinney, C. Barker, G. Lopaschuk, Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation, Circulation 87, 972–981 (1993).

    CAS  PubMed  Google Scholar 

  202. I. Rizos, Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration, Am Heart J 139, S120–3 (2000).

    Article  CAS  PubMed  Google Scholar 

  203. S. Winter, K. Jue, J. Prochazka, P. Francis, W. Hamilton, L. Linn, E. Helton, The role of L-carnitine in pediatric cardiomyopathy, J Child Neurol 10, 2S45–2S51 (1995).

    Google Scholar 

  204. E. Helton, R. Darragh, P. Francis, J. Fricker, K. Jue, G. Koch, D. Mair, M. E. Pierpont, J. V. Prochazka, S. C. Winter, Metabolic aspects of myocardial disease and a role for L-carnitine in the treatment of childhood cardiomyopathy, Pediatrics 105, 1260–1270 (2000).

    CAS  PubMed  Google Scholar 

  205. S. Iliceto, D. Scrutinio, P. Bruzzi, G. D’Ambrosio, L. Boni, M. Di Biase, G. Biasco, P. Hugenholtz, P. Rizzon, on behalf of the CEDIM Investigators. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: The L-carnitine ecocardiografia digitalizzata infarto miocardico (CEDIM) trial, J Am Coll Cardiol 26, 380–7 (1995).

    Article  CAS  PubMed  Google Scholar 

  206. D. V. Cokkinos, Can metabolic manipulation reverse myocardial dysfunction? Editorial Eur Heart J 22, 2138–2139 (2001).

    Article  CAS  Google Scholar 

  207. K. Malmberg, L. Ryden, S. Efendic, J. Herlitz, P. Nicol, A. Waldenstrom, H. Wedel. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Colt Cardol 26, 57–65 (1995).

    Article  CAS  Google Scholar 

  208. I. C. Van der Horst, F. Zijlstra, A. W. van’t Hof, C. J. Doggen, M. J. de Boer, H. Suryapranata, J. C. Hoorntje, J. H. Dambrink, R. O. Gans, H. J. Bilo; Swolle Infarct Study Group, Glucose-insulin potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomised trial, J Am Coll Cardiol 42, 784–91 (2003).

    Article  PubMed  CAS  Google Scholar 

  209. A. K. Jonassen, E. Aasum, R. A. Riemersma, O. D. Mjos, T. S. Larsen, Glucose-insulin-potassium reduces infarct size when administered during reperfusion, Cardiovasc Drugs Ther 14, 615–23 (2001).

    Article  Google Scholar 

  210. M. Tani, J. R. Neely, Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts, Circ Res 65, 1045–56 (1989).

    CAS  PubMed  Google Scholar 

  211. A. Chaudhuri, D. Janicke, M. F. Wilson, D. Tripaty, R. Garg, A. Bandypadhyay, J. Calieri, D. Hoffmeyer, T. Syed, H. Ghanim, A. Aljada, P. Dandona, Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction, Circulation 109, 849–54 (2004).

    Article  CAS  PubMed  Google Scholar 

  212. P. Di Napoli, A. A. Taccardi, A. Grilli, R. Spina, M. Felaco, A. Barsotti, R. De Caterina, Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex-vivo study in isolated working rat hearts, Cardiovasc Res 1, 283–93 (2001).

    Article  Google Scholar 

  213. Q. Feng, X. Lu, D. L. Jones, J. Shen, J. M. 0. Arnold, Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice, Circulation 104, 700–04 (2001).

    CAS  PubMed  Google Scholar 

  214. P. Ferdinandy, H. Danial, I. Ambrus, R. A. Rothery, R. Schulz, Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure, Circ Res 87, 170–2 (2000).

    Google Scholar 

  215. C. Arnaud, D. Godin-Ribuot, S. Bottari, A. Reinnequin, M. Joyeux, P. Demenge, C. Ribuot, iNOS is a mediator of the heat stress-induced preconditioning against myocardial infarction in vivo in the rat, Cardiovasc Res 58, 118–25 (2003).

    Article  CAS  PubMed  Google Scholar 

  216. P, Eaton, D. J. Hearse, M. J. Shattock, Lipid hydroperoxide modification of proteins during myocardial ischemia, Cardiovasc Res 51, 294–303 (2001).

    Article  CAS  PubMed  Google Scholar 

  217. P. T. Koller, SR. Bergmann, Reduction of lipid peroxidation in reperfused isolated rabbit hearts by diltiazem, Circ Res 65, 838–45 (1989).

    CAS  PubMed  Google Scholar 

  218. H. Chen, D. Li, G. J. Roberts, T. Saldeen, JL. Mehta, Eicosipentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat muyocytes, Cardiovasc Res, 59, 7–13 (2003).

    Article  CAS  PubMed  Google Scholar 

  219. B. P. Ander, A. R. Weber, P. P. Rampersad, J. S. Gilchrist, G. N. Pierce, A. Lukas, Dietary flaxseed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholesterolemic rabbits, JU Nutr 134, 3250–6 (2004).

    CAS  Google Scholar 

  220. L.-M. Hung, J.-K. Chen, S.-S. Huang, R.-S. Lee, M.-J. Su, Cardioprotective effect of resveratrol a natural antioxidant derived from grapes, Cardiovasc Res 47, 549–55 (2000).

    Article  CAS  PubMed  Google Scholar 

  221. S. Cuzzocrea, E. Mazzon, G. Constantino, I. Serraino, A. De Sarro, A. Caputi, Effects of n-acetylcysteine in rat model of ischemia and reperfusion injury, Cardiovasc Res 47, 537–48 (2000).

    Article  CAS  PubMed  Google Scholar 

  222. M. Tepel, M. van der Giet, C. Schwarzfeld, U. Laufer, D. Liermann, W. Zidek, Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine, N Engl JMed343, 180–4 (2000).

    Google Scholar 

  223. J. Kay, W. H. Chow, T. M. Chan, S.K. Lo, O.H. Kwok, A. Yip, K. Fan, C.H. Lee, W.F. Lam, Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomised controlled trial, JAMA 289, 553–8 (2003).

    Article  CAS  PubMed  Google Scholar 

  224. K. Spargias, E. Alexopoulos, S. Kyrzopoulos, P. Iakovis, D. C. Greenwood, A. Manginas, V. Voudris, G. Pavlides, C. E. Buller, D. Kremastinos, D. V. Cokkinos, Ascorbic acid prevents contrast-mediated nephropathy in patiens with renal dysfunction undergoing coronary angiography or intervention, Circulation 110, 2837–2842 (2004).

    Article  CAS  PubMed  Google Scholar 

  225. B. Nespereira, M. Perez-Ilzarbe, P. Fernandez, A. M. Fuentes, J. A. Paramo, J. A. Rodriguez, Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice, Atherosclerosis 171, 67–73 (2003).

    Article  CAS  PubMed  Google Scholar 

  226. R. Bolli, M. O. Jeroudi, B. S. Patel, O. I. Aruoma, B. Halliwell, E. K. Lai, P. B. McCay, Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury, Circ Res 65, 607–22 (1989).

    CAS  PubMed  Google Scholar 

  227. S. W. Werns, M. J. Shea, B. R. Lucchesi, Free radicals and myocardial injury: pharmacologic implications, Circulation 74, 1–5 (1986).

    CAS  PubMed  Google Scholar 

  228. R. A. Kloner, K. Przyklenk, S. H. Rahimtoola, E Braunwald, Myocardial stunning and hibernation: mechanisms and clinical implication. In: Stunning, hibernation and calcium in myocardial ischemia and reperfusion, Opie LH, ed. Kluwer Academic Publishers, Boston pp 251–280 (1992).

    Google Scholar 

  229. I. A. Paraskevaidis, E. K. Iliodromitis, D. Vlahakos, D. P. Tsiapras, A. Nikolaids, A. Marathias, A. Michalis, D. T. Kremastinos, Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance, Eur Heart J 26, 263–270 (2005).

    Article  CAS  PubMed  Google Scholar 

  230. D. E. Chambers, D. A. Parks, G. Patterson, R. Roy, J. M. McCord, S. Yoshida, L. F. Parmley, J. M. Downey. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 17, 145–52 (1985).

    CAS  PubMed  Google Scholar 

  231. S. W. Werns, M. J. Shea, S. E. Mitsos, R. C. Dysko, J. C. Fantone, A. Schork, G. D. Abrams, H. B. Pi, B. R. Lucchesi, Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart, Circulation 73, 518–524 ( 1986).

    CAS  PubMed  Google Scholar 

  232. L. B. Stull, M. K. Leppo, L. Szweda, D. Gao, E. Marban, Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy, Circ Res 95, 1005–11 (2001).

    Article  CAS  Google Scholar 

  233. R. M. Fryer, A. K. Hsu, J. T. Eells, H. Nagase, G. J. Gross, Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels., Circ Res 84, 846–51 (1999).

    CAS  PubMed  Google Scholar 

  234. J. N. Peart, G. J. Gross, Morphine-tolerant mice exhibit a profound and persistant cardioprotective phenotype, Circulation 109, 1219–22 (2004).

    Article  CAS  PubMed  Google Scholar 

  235. N. Kokita, A. Hara, Propofol attenuates hydrogen-peroxide induced mechanical and metabolic derangements in the isolated rat heart, Anesthesiology 84, 117–27 (1996).

    Article  CAS  PubMed  Google Scholar 

  236. S. H. Ko, C. W. Yu, S. K. Lee, H. Choe, M. J. Chung, Y. G. Kwak, S. W. Chae, H. S. Song, Propofol attenuates ischemic-reperfusion injury in the isolated rat heart, Anesth Analg 85, 719–24 (1997).

    Article  CAS  PubMed  Google Scholar 

  237. S. A. Javadov, K. H. H. Lim, P. M. Ken; S. Suleiman, G. D. Angelini, A. P. Halestrap, Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition, Cardiovasc Res 45, 360–69 (2000).

    Article  CAS  PubMed  Google Scholar 

  238. D. Branca, E. Vincenti, G. Scutari, Influence of the anesthetic 2,6 — diisopropylphenol (propofol) on isolated rat heart mitochondria, Comp Biochem Physiol C: Pharmacol Toxicol Endocrinol 110, 41–45 (1995).

    Article  CAS  Google Scholar 

  239. V. Borutaite, A. Jekabsone, R. Morkuniene, G. C. Brown, Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome C release and apoptosis induced by heart ischemia, J Moll Cell Cardiol 35, 357–366 (2003).

    Article  CAS  Google Scholar 

  240. C. U. Niemann, M. Saeed, H. Akbari, W. Jacobsen, L. Z. Benet, U. Christinas, N. Serkova, Close association between the reduction in myocardial energy metabolism and infarct size: dose — response assessment of cyclosporine, Pharmacol Exp Ther 302, 1123–8 (2002).

    Article  CAS  Google Scholar 

  241. B. K. Brar, A. Stephanou, Z. Liao, R. M. O’Leary, D. Rennica, D. M. Yellon, D. S. Latchman, Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischemia and at reoxygenation, Cardiovasc Res 51, 265–74 (2001).

    Article  CAS  PubMed  Google Scholar 

  242. K. Suzuki, B. Murtuza, R. T. Smolenski, I. A. Sammut, N. Suzuki, Y. Kaneda, M. H. Yacoub, Over-expression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis, Circulation 104, 1308–13 (2001).

    Google Scholar 

  243. E. F. PDu Toit, C. A. Muller, J. McCarthy, L. H. Opie, Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart, J Pharmacol Exp Ther 290, 505–14 (1999).

    CAS  PubMed  Google Scholar 

  244. C. Pantos, I. Mourouzis, S. Tzeis, P. Moraitis, V. Malliopoulou, D.D. Cokkinos, H. Karageorgiou, D. Varonos, D.V. Cokkinos, Dobutamine administration exacerbates postischemic myocardial dysfunction in isolated rat hearts; an effect reversed by thyroxine pre-treatment, Eur J Pharmacol 460, 155–61 (2003).

    Article  CAS  PubMed  Google Scholar 

  245. G. Calapai, M. C. Marciano, F. Corica, A. Allegra, A. Parisi, N. Frisina, A. P. Caputi, M. Buemi, Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation, Eur J Pharmacol 401, 349–56(2000).

    Article  CAS  PubMed  Google Scholar 

  246. M. A. Bogoyevitch, Review: An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection, Cardiovasc Res 63, 208–16 (2004).

    Article  CAS  PubMed  Google Scholar 

  247. Y. Shi, P. Rafiee, J. Su, K. A. Jr Pritchard, J. S. Tweddell, J. E. Baker, Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels, Basic Res Cardiol 99, 173–82 (2004).

    Article  CAS  PubMed  Google Scholar 

  248. Z. Cai, D. Manalo, G. Wei, E. R. Rodriguez, K. Fox-Talbot, H. Lu, JL. Zweier, G. L. Semenza, Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury, Circulation 108, 79–85 (2003).

    Article  CAS  PubMed  Google Scholar 

  249. T. Rui, Q. Fenf, M. Lei, T. Peng, J. Zhang, M. Xu, E. Dale Abel, A. Xenocostas, P. R. Kvietys, Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1, Cardiovasc Res 65, 19–27 (2005).

    Article  CAS  Google Scholar 

  250. P. Dobsak, J. Siegelova, J. C. Eicher, K. Jancik, H. Svacinova, J. Vascu, S. Kuchtickova, M. Horky, J. E. Wolf. Melatonin protect against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart. Physiology 9, 179–87 (2003).

    CAS  Google Scholar 

  251. E. Sahna, H. Parlakpinar, Y. Turkoz, A. Acet, Protective effects of melatonin on myocardial ischemia reperfusion induced infarct size and oxidative changes, Physiol Res (Epub ahead of print) (2005).

    Google Scholar 

  252. R. J. Reiter, D.-X. Tan, Melatonin: a novel protective agent against oxidative injury of the ischemia reperfused heart, Cardiovasc Res 58, 10–19 (2003).

    Article  CAS  PubMed  Google Scholar 

  253. K. Shinmura, E. Kodani, Y.-T. Xuan, B. Dawn, X.-T. Tang, R. Bolli, Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits, J Am Coll Cardiol 41, 1183–94 (2003).

    Article  CAS  PubMed  Google Scholar 

  254. K. Przyklenk, G. Heusch, Late preconditioning against myocardial stunning. Does aspirin close the “second window” of endogenous cardioprotection? J Am Coll Cardiol 41, 1195–7 (2003).

    Article  PubMed  Google Scholar 

  255. J. F. Bouchard, D. Lamontagne, Protection afforded by preconditioning to the diabetic heart against ischemic injury, Cardiovasc Res 37, 82–90 (1998).

    Article  CAS  PubMed  Google Scholar 

  256. Z. Yang, S. S. Berr, W. D. Gilson, M.-C. Toufektsian, B. A. French, Simultanous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction, Circulation 09, 1161–67 (2004).

    Article  Google Scholar 

  257. M. Amrani, N. Latif, K. Morrison, C. C. Gray, J. Jayakumar, J. Corbett, A. T. Goodwin, M. J. Dunn, M. H. Yacoub, Relative induction of heat shock protein in coronary endothelial cells and cardiomyocytes: implications for myocardial protection, J Thorac Cardiovasc Sirg 115, 200–9 (1998).

    Article  CAS  Google Scholar 

  258. Y. Hayashi, Y. Sawa, N. Fukuyama, H. Nakazawa, H. Matsuda, Preoperative glutamine administration induces heat-shock protein 70 expression and attenuates cardiopulmonary bypass-induced inflammatory response by regulating nitric oxide synthase activity, Circulation 106, 2601–07 (2002).

    Article  CAS  PubMed  Google Scholar 

  259. H. Duplain, R. Burcelin, C. Sartori, S. Cook, M. Egli, M. Lepori, P. Vollenweider, T. Pedrazzini, P. Nicod, B. Thorens, U. Scherrer, Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104, 342–5 (2001).

    CAS  PubMed  Google Scholar 

  260. M. E. Widlansky, N. Gokce, J. F. Keaney, J. A. Vita, The clinical implications of endothelial dysfunction, J Am Coll Cardiol 42, 1149–60 (2003).

    Article  CAS  PubMed  Google Scholar 

  261. P. Di Napoli, A. A. Taccardi, A. Barsotti, Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischemic dilated cardiomyopathy, Heart 91, 161–45 (2005).

    Article  PubMed  CAS  Google Scholar 

  262. T. M. Lee, T. F. Chou, Troglitazone administration limits infarct size by reduced phosphorylation of canine myocardial connexin 43 proteins, Am J Physiol. Heart Circ Physiol 85, HI650–59 (2003).

    Google Scholar 

  263. T. L. Yue, J. Chen, W. Bao, P. K. Narayanan, A. Bril, W. Jiang, P. G. Lysko, J. L. Gu, R. Boyce, D. M. Zimmerman, T. K. Hart, R. E. Buckingham, E. H. Ohlstein, In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone, Circulation 104, 2588–94 (2001).

    CAS  Google Scholar 

  264. H.-R. Liu, L. Tao, E. Gao, B. L. Lopez, T. A. Christopher, R. N. Willette, E. H. Ohlstein, T. L. Yue, X. L. Ma, Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion, Cardiovasc Res 62, 135–44 (2004).

    Article  CAS  PubMed  Google Scholar 

  265. E. O. Weinberg, M. Schemer-Crosbie, M. H. Picard, B. A. Nasseri, MacGillivray, J. Cannon, Q. Lian, K. D. Bloch, R. T. Lee, Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion, Am J Physiol-Heart and Circulatory Physiology 288, H1802–H1809 (2005).

    Article  CAS  Google Scholar 

  266. S.R. Mehta, S. Yusuf, R. Dim, J. Zhu, P. Pais, D. Xavier, E. Paolasso, R. Ahmed, C. Xie, K. Kazmi, J. Tai, A. Orlandini, J. Pogue, L. Liu; CREATE-ECLA Trial Group Investigators, Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial, JAMA. 293(4), 437–446 (2005).

    Article  PubMed  Google Scholar 

  267. P. Theroux, B.R. Chaitman, L. Erhardt, A. Jessel, T. Meinertz, W.U. Nickel, J.S. Schroeder, G. Tognoni, H. White and J.T. Willerson, Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial, Curr Control Trials Cardiovasc Med. 1(1), 59–67 (2000).

    Article  CAS  PubMed  Google Scholar 

  268. R.M. Mentzer Jr, Sodium-proton exchange inhibition to prevent coronary events in acute cardiac conditions trial, Paper presented at the American Heart Association Scientific Sessions. November 12, (2003).

    Google Scholar 

  269. J. Sochman, J. Vrbska, B. Musilova and M. Rocek, Infarct Size Limitation: acute N-acetylcysteine defense (ISLAND trial): preliminary analysis and report after the first 30 patients, Clin Cardiol. 19(2), 94–100 (1996).

    Article  CAS  PubMed  Google Scholar 

  270. V. Marangelli, C. Memmola, M.S. Brigiani, L. Boni, M.G. Biasco, D. Scrutinio, S. Iliceto and P. Rizzon, Early administration of verapamil after thrombolysis in acute anterior myocardial infarction. Effect on left ventricular remodeling and clinical outcome. VAMI Study Group. Verapamil Acute Myocardial Infarction, Ital Heart J. 1(5), 336–343 (2000).

    CAS  PubMed  Google Scholar 

  271. P. Theroux, J. Gregoire, C. Chin, G. Pelletier, P. de Guise and M. Juneau, Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial, J Am Coll Cardiol. 32(3), 620–628 (1998).

    Article  CAS  PubMed  Google Scholar 

  272. S.L. Kopecky, R.J. Aviles, M.R. Bell, J.K. Lobl, D. Tipping, G. Frommell, K. Ramsey, A.E. Holland, M. Midei, A. Jain, M. Kellett and R.J. Gibbons, A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (Amp579 Delivery for Myocardial Infarction REduction) study, Am. Heart J. 146(1), 146–152 (2003).

    Article  CAS  PubMed  Google Scholar 

  273. S.L. Kopecky, R.J. Aviles, M.R. Bell, J.K. Lobl, D. Tipping, G. Frommell, K. Ramsey, A.E. Holland, M. Midei, A. Jain, M. Kellett and R.J. Gibbons, A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (Amp579 Delivery for Myocardial Infarction REduction) study, Am. Heart J. 146(1), 146–152 (2003).

    Article  CAS  PubMed  Google Scholar 

  274. M. Quintana, P. Hjemdahl, A. Sollevi, T. Kahan, M. Edner, N. Rehnqvist, E. Swahn, A.C. Kjerr P. Nasman; ATTACC investigators, Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the AT-Tenuation by Adenosine of Cardiac Complications (ATTACC) study, Eur J Clin Pharmacol. 59(1), 1–9 (2003).

    CAS  PubMed  Google Scholar 

  275. S. Von Haehling, S. D. Anker, Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism? Heart 91, 1–2 (2005).

    Article  Google Scholar 

  276. C. Communal, W. S. Colucci, The control of cardiomyocyte apoptosis via the β-adrenergic signaling pathways, Arch Mol Coeur 98, 236–41 (2005).

    CAS  Google Scholar 

  277. D. V. Sawyer, D. A. Siwik, L. Xiao, D. R. Pimentel, K. Singh, W. S. Colucci, Role of oxidative stress in myocardial hypertrophy and failure, J Mol Cell Cardiol 34, 379–88 (2002).

    Article  CAS  PubMed  Google Scholar 

  278. G. T. O’Connor, J. E. Buring, S. Yusuf, S. Z. Goldhaber, E. M. Olmstead, R. S. Jr Paffenbarger, C. H. Hennekens, An overview of randomized trials of rehabilitation with exercise after myocardial infarction, Circulation 80, 234–45 (1989).

    CAS  PubMed  Google Scholar 

  279. R. Bellardinelli, D. Georgiou, G. Cianci, A. Purcaro, Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effect on functional capacity, quality of life, and clinical outcome, Circulation 99, 1173–82 (1999).

    Google Scholar 

  280. S. Freimann, Scheinowitz, D. Yekutieli, M. S. Feinberg, M. Eldar, G. Kessler-Icekson, Prior exercise training improves the outcome of acute myocardial infarction in the rat: Heart structure, funation, and gene expression, J Am Coll Cardiol 45, 931–8 (2005).

    Article  PubMed  Google Scholar 

  281. R. A. Kloner, S. H. Rezkalla, Cardiac protection during acute myocardial infarction: Where do we stand in 2004? J Am Coll Cardiol 44, 276–86 (2004).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical School, University of Athens, Greece

    Dennis V. Cokkinos (Professor of Cardiology)

Authors
  1. Dennis V. Cokkinos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dennis V. Cokkinos .

Editor information

Editors and Affiliations

  1. Cardiology Dept., Onassis Cardiac Surgery Center, University of Athens, Athens, Greece

    Dennis V. Cokkinos MD, PhD (Prof. of Cardiology, Chairman) (Prof. of Cardiology, Chairman)

  2. Depart. Of Pharmacology, Medical School, University of Athens, Athens, Greece

    Constantinos Pantos MD, PhD (Assistant Professor of Pharmadcology) (Assistant Professor of Pharmadcology)

  3. Institute of Pathophysiology, Department of Internal Medicine, University of Essen, Essen, Germany

    Gerd Heusch MD, PhD (Professor of Medicine, Director) (Professor of Medicine, Director)

  4. Division of Cardiology, The University of Texas Houston Medical School, Houston, Texas, USA

    Heinrich Taegtmeyer MD, DPhil (Professor of Medicine, Co-Director) (Professor of Medicine, Co-Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Cokkinos, D.V. (2006). Myocardial Protection — From Concepts to Clinical Practice. In: Cokkinos, D.V., Pantos, C., Heusch, G., Taegtmeyer, H. (eds) Myocardial Ischemia. Basic Science for the Cardiologist, vol 21. Springer, Boston, MA. https://doi.org/10.1007/0-387-28658-6_8

Download citation

  • DOI: https://doi.org/10.1007/0-387-28658-6_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-28657-0

  • Online ISBN: 978-0-387-28658-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation